Healthcare services company True Health revealed on Monday the launch of a comprehensive testing that will provide clinicians with useful diagnostics to determine the specific cause of symptoms in celiac disease and gluten related disorders.

According to the Celiac Disease Foundation, about 80% of individuals in the US with celiac disease are undiagnosed despite an increasing awareness of the disease. Gluten-related conditions, including celiac disease, wheat allergy and non-celiac gluten sensitivity, may produce identical symptoms, making accurate diagnosis challenging and potentially causing unnecessary suffering among those who experience symptoms.

The True Health Celiac Disease and Gluten Sensitivity Profile reportedly incorporates seven US FDA-approved specific wheat-based serologic markers that can differentiate wheat allergy, celiac disease and non-celiac gluten sensitivity.

In addition, biomarkers are available to order as individual tests, or as a comprehensive profile, to help provide simultaneous diagnostic information about multiple conditions in a single blood draw. The company's comprehensive testing offer additional clinical assessment and effective patient management.